TRON presents research at CIMT 2014

Mainz, Germany, May 5, 2014– With more than 15 scientific abstracts and 4 plenary and short talks, TRON scientists present their latest research at the 12th Annual Meeting of the Association for Cancer Immunotherapy (CIMT), May 6-8, 2014 in Mainz, Germany. TRON founder and scientific director Ugur Sahin will give a plenary presentation on innate and adaptive immunity for personalized cancer immunotherapy. John Castle, Co-Director of the TRON Biomarker Development Center presents as part of the Feature Session on Immunoinformatics and Genomics. In addition, two TRON abstract authors will present their research as short talks. CIMT is the largest European meeting focused on cancer immunotherapy research and development.

For more information, go to

TRON presentations at CIMT 2014:

May 6, 11.00 – 11.30
Congress Hall Plenary Session 1 / Tumor Vaccination
Ugur Sahin
TRON (Mainz, Germany) – Modulating innate and adaptive immunity for personalized cancer immunotherapy

May 7, 10.00 – 10.150
Congress Hall Short Talk Session I / Therapeutic Vaccination
Lena Kranz
(#32) TRON (Mainz, Germany) – Characterization of the IFNα response upon systemic administration of targeted mRNA vaccine delivery

May 7, 10:00 – 10:150
Gutenberg A Short Talk Session II / New Targets & New Lead
11:30 – 11:45 Marius Byl

(#88) TRON (Mainz, Germany) – TRON Expression Atlas (TEA): A web – based platform for archival, retrieval,filtering and visualization of high throughput gene expression profiles

May 7, 17:30 – 18:05
Congress Hall Feature Session / Immunoinformatics and Genomics
John Castle
TRON (Mainz, Germany) – Bioinformatics and genomics for individualized immunotherapies

For a detailed conference program, please go to